Please DONATE to support this urgently needed FREE testing program. **FOR IMMEDIATE RELEASE** BEDFORD RESEARCH FOUNDATION CLINICAL LABORATORY WILL BE TESTING FOR COVID19. As part of its mission to support treatment of currently incurable diseases in communities, the Bedford Research Foundation clinical laboratory, located in Massachusetts, will begin offering a highly sensitive highly specific test…
Read More›The Activated Egg Symposium 2019 brought together thought leaders in circadian rhythms, human egg parthenogenesis, human-animal chimeras for disease research and drug modeling, and the ethics of gene editing human embryos. It was an extraordinarily successful gathering with both speakers and attendees taking away new, important information.
Read More›Read about all of the progress and the research that has occurred at the Foundation over the course of the past year. Unfertilized eggs can be activated artificially (parthenogenesis) to undergo cell multiplications similar to fertilized eggs, but do not give rise to offspring. At the time of activation, a protein responsible for tissue rejection can be silenced by gene editing.
Read More›Our goal for 2017 was to improve the efficiency of a new technology, “gene editing” by CRISPR, that can precisely edit genes in eggs activated to become stem cells. BRF scientists accomplished this goal in a mouse model by developing new methods that improve the efficiency of CRISPR gene editing in mouse eggs.
The Bedford Research Foundation is seeking a scientific director to lead its program to derive parthenogenetic stem cells from unfertilized human eggs. Experience with human eggs and stem cell derivation is required. Proven success in obtaining grant funding and a strong publication record are also required. Learn More
The latest newsletter include a chronicle of our milestones over the past 20 years, news about our stem cell program with gene editing, Universal Mouse Model Stem Cell Resistant To HIV Infection, our prostate disease research, a new staff member, a new board member and more exciting new growth at our Bedford office.
With the help of generous philanthropists and medical collaborators, Dr. Ann Kiessling founded the Bedford Research Foundation in 1996 to address a research need that could not be federally funded — how to help men infected by HIV through tainted blood transfusions have children without infecting their wives and babies. The first “Special Program for…
The Bedford Research Foundation welcomes two new board members to the Board of Trustees: Larry LaFranchi, Ellen Sheehy and Scott Anderson. Larry LaFranchi brings more than 30 years of business and entrepreneurial experience. His passion for health care and is a perfect match for the Foundation’s independent research goals, and his expertise in financial planning…
This past year BRF helped sponsor a research fellow, Sebastian Bernabe, in Andulacia, Spain’s new stem cell research center. Formerly a research fellow with Foundation Trustee Dr. Jose Cibelli at Michigan State University, Dr. Bernabe joined the spinal cord research team developed with Spanish scientists Dr. Cibelli and Dr. Philip Horner. The goal of the…
Bedford Research scientists are launching research to derive new stem cells from unfertilized human eggs. These cells, termed “parthenote” stem cells, are being developed to fulfill the need for “off the shelf” stem cell treatments, similar to emergency transfusion with blood bank blood. The past decade of discoveries by BRF scientists provide the ground work…